{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:35:00Z","timestamp":1777887300644,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.gassur.2026.102392","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:08:35Z","timestamp":1772525315000},"page":"102392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of lenvatinib as adjuvant therapy for hepatocellular carcinoma with vascular invasion after curative resection"],"prefix":"10.1016","volume":"30","author":[{"given":"De-Hua","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7108-2520","authenticated-orcid":false,"given":"Shao-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gassur.2026.102392_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"10.1016\/j.gassur.2026.102392_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gassur.2026.102392_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0000000000003268","article-title":"Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation","volume":"273","author":"Lee","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.gassur.2026.102392_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.surg.2022.05.023","article-title":"Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0\/A hepatocellular carcinoma: a large-scale multicenter study","volume":"172","author":"Feng","year":"2022","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.gassur.2026.102392_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","article-title":"A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma","volume":"137","author":"Roayaie","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gassur.2026.102392_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1245\/s10434-012-2513-1","article-title":"A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability","volume":"20","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2026.102392_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications","volume":"243","author":"Portolani","year":"2006","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.gassur.2026.102392_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gassur.2026.102392_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000504193","volume":"9","author":"Shindoh","year":"2020","journal-title":"Liver Cancer"},{"issue":"8","key":"10.1016\/j.gassur.2026.102392_bib10","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1245\/s10434-019-07365-0","article-title":"Prognostic value and prediction of extratumoral microvascular invasion for hepatocellular carcinoma","volume":"26","author":"Nitta","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2026.102392_bib11","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1634\/theoncologist.2019-0766","article-title":"Novel models predict postsurgical recurrence and overall survival for patients with hepatitis B virus-related solitary hepatocellular carcinoma \u226410 cm and without portal venous tumor thrombus","volume":"25","author":"Wang","year":"2020","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.gassur.2026.102392_bib12","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/gutjnl-2018-315983","article-title":"Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial","volume":"67","author":"Chen","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.gassur.2026.102392_bib13","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.22.01142","article-title":"Postoperative adjuvant hepatic arterial infusion chemotherapy with FOLFOX in hepatocellular carcinoma with microvascular invasion: a multicenter, Phase III, randomized study","volume":"41","author":"Li","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10415","key":"10.1016\/j.gassur.2026.102392_bib14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gassur.2026.102392_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41591-023-02786-7","article-title":"Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"issue":"10126","key":"10.1016\/j.gassur.2026.102392_bib16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gassur.2026.102392_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S1470-2045(23)00469-2","article-title":"Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial","volume":"24","author":"Llovet","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102392_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO.22.00392","article-title":"Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)","volume":"41","author":"Peng","year":"2023","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.gassur.2026.102392_bib19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2026.102392_bib20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1200\/JCO.2002.07.089","article-title":"Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study","volume":"20","author":"Poon","year":"2002","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102392_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000494844","article-title":"Newly proposed ALBI grade and ALBI-T score as tools for assessment of hepatic function and prognosis in hepatocellular carcinoma patients","volume":"8","author":"Hiraoka","year":"2019","journal-title":"Liver Cancer"},{"issue":"9","key":"10.1016\/j.gassur.2026.102392_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S2468-1253(19)30178-5","article-title":"Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west","volume":"4","author":"Lu","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102392_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ijc.33516","article-title":"Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma","volume":"149","author":"Wang","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.gassur.2026.102392_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/SLA.0000000000004350","article-title":"Liver resection versus local ablation therapies for hepatocellular carcinoma within the Milan criteria: a systematic review and meta-analysis","volume":"273","author":"Shin","year":"2021","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gassur.2026.102392_bib25","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ejso.2021.12.466","article-title":"A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion","volume":"48","author":"Wang","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102392_bib26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2024.01.018","article-title":"Navigating the landscape of liver cancer management: study designs in clinical trials and clinical practice","volume":"80","author":"Cabibbo","year":"2024","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102392_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.32411","article-title":"Dynamic risk profiling of HCC recurrence after curative intent liver resection","volume":"76","author":"Ivanics","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.gassur.2026.102392_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/JHC.S447848","article-title":"Macroscopic characterization of hepatocellular carcinoma: an underexploited source of prognostic factors","volume":"11","author":"Gonvers","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.gassur.2026.102392_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.01.006","article-title":"Updated data from IMbrave050: adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma","author":"Yopp","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.gassur.2026.102392_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241258394","article-title":"Adjuvant donafenib for hepatocellular carcinoma patients at high risk of recurrence after radical resection: a real-world experience","volume":"16","author":"Zhang","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.gassur.2026.102392_bib31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/JHC.S516478","article-title":"Adjuvant lenvatinib for high-risk CNLC IIb\/IIIa hepatocellular carcinoma after curative hepatectomy: a prospective exploratory study","volume":"12","author":"Sun","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.gassur.2026.102392_bib32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2147\/JHC.S424616","article-title":"Adjuvant lenvatinib plus PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy: a retrospective landmark analysis","volume":"10","author":"Ouyang","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"10.1016\/j.gassur.2026.102392_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.hbpd.2025.03.001","article-title":"Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: a multicenter prospective cohort study","volume":"24","author":"Chen","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"10.1016\/j.gassur.2026.102392_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf139","article-title":"Adjuvant transarterial chemoembolization plus lenvatinib for patients with HCC with MVI after resection: a multicenter retrospective study","volume":"30","author":"Hou","year":"2025","journal-title":"Oncologist"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X26000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X26000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:07:50Z","timestamp":1777608470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X26000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1091255X26000739"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102392","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of lenvatinib as adjuvant therapy for hepatocellular carcinoma with vascular invasion after curative resection","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102392"}}